Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the Executive Director, Head of Contracting, this role will provide leadership and oversight for contracting strategies and activities supporting the company’s contract needs, including management support for assigned attorneys, contract managers and contract administrators. The Senior Director, Contracting will assess evolving contracting needs in a quickly changing environment, support Contract Lifecycle Management system change, maintain strong client and customer relationships, and help manage service level goals for the contracting function. The position is a leadership role and will be instrumental in facilitating the growth of RevMed's contracts department.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree